Inotiv (NOTV)
(Delayed Data from NSDQ)
$1.37 USD
-0.08 (-5.52%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.38 +0.01 (0.73%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NOTV 1.37 -0.08(-5.52%)
Will NOTV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NOTV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NOTV
Inotiv, Inc. (NOTV) Reports Q3 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates
NOTV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates
Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates
Will Nektar Therapeutics (NKTR) Report Negative Q1 Earnings? What You Should Know
Other News for NOTV
Non-ADX 1,2,3,4 Bearish appears for NOTV after 5.52% move
The technical outlook for NOTV is unchanged after it rises 9.02% on September 19
NOTV forms Stochastic Buy Signal on September 18
Is NOTV heading for a slide? New 52 Week Closing Low shows up after sliding 1.46%
Is NOTV preparing to trend lower? New 52 Week Closing Low shows up after dropping 2.84%